Additionally, the Human Protein Atlas resource revealed high expression of BIRC5 or PLK1 to be associated with poor survival in renal, liver, and lung cancer patients and high expression of ROCK1 to be a marker of unfavorable prognosis in pancreatic cancer [18]. Here, BIRC5 is linked to familial pancreatic carcinoma.